Payment overview · 2025
General Payments
$116.55
1 reported records · 1 companies
Healthcare provider profile · identity verified
Thomas C Luiskutty, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · TULSA, OK · NPI 1447238654
Verified facts
What the public records show
CMS Open Payments records show Thomas C Luiskutty, M.D. received $116.55 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 74 claims for Nuedexta by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 76 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $116.55 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $116.55 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $116.55 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 76 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
74 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
76 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1141 | 155 |
| Atorvastatin Calcium | Atorvastatin Calcium | 873 | 209 |
| Furosemide | Furosemide | 837 | 159 |
| Eliquis | Apixaban | 582 | 101 |
| Potassium Chloride | Potassium Chloride | 570 | 128 |
| Amlodipine Besylate | Amlodipine Besylate | 564 | 137 |
| Gabapentin | Gabapentin | 564 | 139 |
| Pantoprazole Sodium | Pantoprazole Sodium | 462 | 107 |
| Donepezil Hcl | Donepezil Hcl | 440 | 102 |
| Trazodone Hcl | Trazodone Hcl | 424 | 95 |
| Losartan Potassium | Losartan Potassium | 367 | 74 |
| Sertraline Hcl | Sertraline Hcl | 367 | 91 |
| Carvedilol | Carvedilol | 339 | 83 |
| Memantine Hcl | Memantine Hcl | 331 | 81 |
| Clopidogrel | Clopidogrel Bisulfate | 321 | 63 |
| Lisinopril | Lisinopril | 312 | 76 |
| Metoprolol Tartrate | Metoprolol Tartrate | 303 | 90 |
| Tamsulosin Hcl | Tamsulosin Hcl | 299 | 79 |
| Mirtazapine | Mirtazapine | 295 | 67 |
| Metoprolol Succinate | Metoprolol Succinate | 276 | 69 |
| Escitalopram Oxalate | Escitalopram Oxalate | 246 | 60 |
| Xarelto | Rivaroxaban | 239 | 34 |
| Metformin Hcl | Metformin Hcl | 226 | 48 |
| Divalproex Sodium | Divalproex Sodium | 224 | 46 |
| Duloxetine Hcl | Duloxetine Hcl | 221 | 52 |
| Omeprazole | Omeprazole | 217 | 67 |
| Famotidine | Famotidine | 212 | 51 |
| Buspirone Hcl | Buspirone Hcl | 185 | 51 |
| Fluticasone Propionate | Fluticasone Propionate | 181 | 49 |
| Jardiance | Empagliflozin | 178 | 31 |
| Levetiracetam | Levetiracetam | 177 | 43 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 143 | 37 |
| Olanzapine | Olanzapine | 134 | 37 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 124 | 29 |
| Montelukast Sodium | Montelukast Sodium | 124 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 118 | 38 |
| Quetiapine Fumarate | Quetiapine Fumarate | 117 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 115 | 35 |
| Fluoxetine Hcl | Fluoxetine Hcl | 114 | 28 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 113 | 19 |
| Farxiga | Dapagliflozin Propanediol | 113 | 12 |
| Simvastatin | Simvastatin | 113 | 26 |
| Latanoprost | Latanoprost | 112 | 24 |
| Allopurinol | Allopurinol | 109 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 108 | 26 |
| Ondansetron Hcl | Ondansetron Hcl | 106 | 66 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 106 | 28 |
| Trulicity | Dulaglutide | 105 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 96 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 95 | 25 |
| Januvia | Sitagliptin Phosphate | 93 | 11 |
| Baclofen | Baclofen | 87 | 25 |
| Oxybutynin Chloride | Oxybutynin Chloride | 86 | 15 |
| Spironolactone | Spironolactone | 86 | 35 |
| Myrbetriq | Mirabegron | 85 | 13 |
| Torsemide | Torsemide | 84 | 26 |
| Midodrine Hcl | Midodrine Hcl | 83 | 21 |
| Meloxicam | Meloxicam | 79 | 25 |
| Ondansetron Odt | Ondansetron | 77 | 39 |
| Clonidine Hcl | Clonidine Hcl | 76 | 29 |
| Rexulti | Brexpiprazole | 76 | suppressed |
| Risperidone | Risperidone | 76 | 17 |
| Bupropion Hcl | Bupropion Hcl | 74 | 19 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 74 | suppressed |
| Finasteride | Finasteride | 72 | 23 |
| Lamotrigine | Lamotrigine | 72 | 16 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 68 | 28 |
| Bupropion Xl | Bupropion Hcl | 67 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 66 | 33 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 65 | 14 |
| Topiramate | Topiramate | 63 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 62 | 26 |
| Entresto | Sacubitril/Valsartan | 62 | 11 |
| Sucralfate | Sucralfate | 61 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 58 | 31 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 58 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 57 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 57 | 11 |
| Aripiprazole | Aripiprazole | 55 | 16 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 55 | 26 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 55 | 20 |
| Hydrochlorothiazide | Hydrochlorothiazide | 54 | 14 |
| Warfarin Sodium | Warfarin Sodium | 54 | suppressed |
| Brilinta | Ticagrelor | 53 | suppressed |
| Lorazepam | Lorazepam | 53 | 19 |
| Tramadol Hcl | Tramadol Hcl | 53 | 17 |
| Novolog Flexpen | Insulin Aspart | 52 | 21 |
| Ropinirole Hcl | Ropinirole Hcl | 52 | 12 |
| Albuterol Sulfate | Albuterol Sulfate | 51 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 51 | 26 |
| Prednisone | Prednisone | 51 | 28 |
| Timolol Maleate | Timolol Maleate | 49 | suppressed |
| Valsartan | Valsartan | 49 | 11 |
| Levofloxacin | Levofloxacin | 48 | 39 |
| Nystatin | Nystatin | 48 | 25 |
| Doxazosin Mesylate | Doxazosin Mesylate | 47 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 46 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 46 | suppressed |
| Digoxin | Digoxin | 46 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 46 | 16 |
| Riluzole | Riluzole | 46 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 45 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 43 | suppressed |
| Glipizide | Glipizide | 42 | suppressed |
| Celecoxib | Celecoxib | 41 | 12 |
| Methocarbamol | Methocarbamol | 41 | 18 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Ezetimibe | Ezetimibe | 40 | 12 |
| Gemtesa | Vibegron | 39 | suppressed |
| Ibuprofen | Ibuprofen | 39 | 19 |
| Insulin Aspart Flexpen | Insulin Aspart | 39 | 18 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 38 | 12 |
| Clonidine | Clonidine | 38 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 38 | suppressed |
| Vraylar | Cariprazine Hcl | 38 | suppressed |
| Lacosamide | Lacosamide | 37 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 37 | 28 |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Enulose | Lactulose | 35 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 35 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | 14 |
| Metolazone | Metolazone | 35 | 12 |
| Tradjenta | Linagliptin | 35 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 33 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 33 | suppressed |
| Lidocaine | Lidocaine | 32 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 32 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 31 | suppressed |
| Hydrocortisone | Hydrocortisone | 30 | 14 |
| Linzess | Linaclotide | 30 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 30 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 30 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 30 | 23 |
| Alendronate Sodium | Alendronate Sodium | 29 | suppressed |
| Fluconazole | Fluconazole | 29 | 23 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 29 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 29 | suppressed |
| Clotrimazole | Clotrimazole | 28 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 28 | 23 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 28 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 27 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 27 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 27 | suppressed |
| Haloperidol | Haloperidol | 27 | suppressed |
| Pentoxifylline | Pentoxifylline | 27 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 27 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 26 | 26 |
| Levalbuterol Hcl | Levalbuterol Hcl | 26 | suppressed |
| Loperamide | Loperamide Hcl | 26 | 18 |
| Megestrol Acetate | Megestrol Acetate | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | 11 |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 25 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 25 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 24 | 19 |
| Easy Touch Safety Pen Needle | Pen Needle, Diabetic, Safety | 24 | suppressed |
| Meropenem | Meropenem | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 21 |
| Oxcarbazepine | Oxcarbazepine | 23 | suppressed |
| Verapamil Er | Verapamil Hcl | 23 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 22 | suppressed |
| Glimepiride | Glimepiride | 22 | suppressed |
| Phenytek | Phenytoin Sodium Extended | 22 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 22 | suppressed |
| Atenolol | Atenolol | 21 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 21 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 21 | suppressed |
| Mupirocin | Mupirocin | 21 | 16 |
| Ozempic | Semaglutide | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 19 |
| Estradiol | Estradiol | 20 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 20 | suppressed |
| Dexamethasone | Dexamethasone | 19 | 19 |
| Fenofibrate | Fenofibrate,micronized | 19 | suppressed |
| Azithromycin | Azithromycin | 18 | 17 |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 18 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 18 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 18 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Lactulose | Lactulose | 17 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 17 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Bumetanide | Bumetanide | 16 | suppressed |
| Calcium Acetate | Calcium Acetate | 16 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 16 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Clozapine | Clozapine | 16 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 16 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 16 | 16 |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Nystop | Nystatin | 16 | 13 |
| Ranolazine Er | Ranolazine | 16 | suppressed |
| Acetic Acid | Acetic Acid | 15 | suppressed |
| Austedo Xr | Deutetrabenazine | 15 | suppressed |
| Griseofulvin | Griseofulvin, Microsize | 15 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 15 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 15 | suppressed |
| Ramelteon | Ramelteon | 15 | suppressed |
| Scopolamine | Scopolamine | 15 | suppressed |
| Anastrozole | Anastrozole | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Movantik | Naloxegol Oxalate | 14 | suppressed |
| Multaq | Dronedarone Hcl | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 14 |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Levemir | Insulin Detemir | 13 | suppressed |
| Nyamyc | Nystatin | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Pregabalin | Pregabalin | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Alprazolam | Alprazolam | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 12 | suppressed |
| Erythromycin Ethylsuccinate | Erythromycin Ethylsuccinate | 12 | suppressed |
| Kerendia | Finerenone | 12 | suppressed |
| Linezolid-D5w | Linezolid In Dextrose 5% | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 11 | suppressed |
| Ingrezza | Valbenazine Tosylate | 11 | suppressed |
| Linezolid | Linezolid | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Propylthiouracil | Propylthiouracil | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Trospium Chloride | Trospium Chloride | 11 | suppressed |
| Valproic Acid | Valproic Acid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $116.55 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error